Journals / Çocuk Enfeksiyon Dergisi / 2012 / Cilt: 6 - Sayı: 4

Fatco sendromlu ımmunsağlıklı bir çocukta aspergillus flavus nedenli osteomyelit due to aspergillus flavus in an: bir olgu sunumu ve literatürün gözden geçirilmesi

Osteomyelitis due to aspergillus flavus in an ımmunocompetent child with fatco syndrome: a case report and literature review

Pages
163–166
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, invasive Aspergillus infections can affect immunocompetent adults and children.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:An 8-year-old boy, with fibular agenesis, tibial cam- pomelia, and oligosyndactyly (FATCO syndrome), had been operated on for reconstruction 3 weeks prior at another hospital.
📊
Key Findings & Data:A microbiological examination yielded a filamentous fungus from three different specimens that was identified as Aspergillus flavus.
💡
Conclusion & Impact:In conclusion, invasive Aspergillus infections can affect immunocompetent adults and children.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

An 8-year-old boy, with fibular agenesis, tibial cam- pomelia, and oligosyndactyly (FATCO syndrome), had been operated on for reconstruction 3 weeks prior at another hospital. He was admitted to our hospital because of right leg pain and purulent exu- dates from the surgical wound site for one week. Physical examination revealed purulent material at the surgical wound on the right leg. Radiological examination confirmed the clinical diagnosis as osteomyelitis. Clinical findings did not improve with empirical antibacterial therapy. A microbiological examination yielded a filamentous fungus from three different specimens that was identified as Aspergillus flavus. The patient was treated successfully with oral itraconazole for 6 weeks. In conclusion, invasive Aspergillus infections can affect immunocompetent adults and children. Trauma and surgical intervention can also be a risk factor for immunocompetent indi- viduals. In addition to surgery, itraconazole can be a good choice in the treatment of Aspergillus osteomy- elitis, especially in children. (J Pediatr Inf 2012; 6: 163-6)

Özet

Fibula yokluğu, tibiada kampomeli ve oligosindaktilisi olan (FATCO sendromu) 8 yaşındaki bir erkek çocuk, üç hafta önce başka bir hastanede rekonstrüksiyon amacıyla opere olmuştu. Bir haftadır devam eden sağ bacak ağrısı ve cerrahi yara bölgesinden pürülan akıntı şikayeti ile hastanemize başvurdu. Fizik muaye- nede sağ bacaktaki cerrahi yarada pürülan materyal gözlendi. Radyolojik incelemeler klinik osteomyelit tanısı ile uyumlu bulundu. Ampirik olarak başlanan antibakteriyel tedavi klinik bulgularda iyileşme sağla- madı. Mikrobiyolojik incelemelerde üç farklı klinik örnekten filamantöz bir mantar izole edildi ve bu man- tar Aspergillus flavus olarak tanımlandı. Hastaya oral itrakonazol ile 6 haftalık başarılı bir tedavi uygulandı. Sonuç olarak, invaziv Aspergillus enfeksiyonları immünsağlıklı erişkin ve çocukları etkileyebilir. Travma ve cerrahi müdahaleler immünsağlıklı bireyler için risk faktörü olarak ortaya çıkabilir. Cerrahiye ilave olarak itrakonazol, özellikle çocuklardaki Aspergillus oste- omyelitinin tedavisinde iyi bir seçenek olabilir. (J Pediatr Inf 2012; 6: 163-6)

🔖

Cite This Article

ÖZ, Y., DİNLEYİCİ, E. Ç., İNAN, U., KİRAZ, N. (2012). Fatco sendromlu ımmunsağlıklı bir çocukta aspergillus flavus nedenli osteomyelit due to aspergillus flavus in an: bir olgu sunumu ve literatürün gözden geçirilmesi. Çocuk Enfeksiyon Dergisi, Cilt: 6 - Sayı: 4, 163–166. https://ajindex.com/articles/209696

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Hinrikson HP, Hurst SF, Lott TJ, Warnock DW, Morrison CJ. Assessment of ribosomal large-subunit D1-D2, internal tran- scribed spacer 1, and internal transcribed spacer 2 regions as targets for molecular identification of medically important Aspergillus species. J Clin Microbiol 2005
  2. [CrossRef] 2. Steinbach J, Stevens DA, Denning DW. Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001. Clin Infect Dis 2003
  3. [CrossRef] 3. Zhu LP, Chen XS, Wu JQ, Yang FF, Weng XH. Aspergillus ver- tebral osteomyelitis and ureteral obstruction after liver trans- plantation. Transpl Infect Dis 2011
  4. [CrossRef] 4. Verghese S, Chellamma T, Cherian KM. Osteomyelitis of the rib caused by Aspergillus flavus following cardiac surgery. Mycoses 2009
  5. [CrossRef] 5. Garazzino S, Maiello A, de Rosa FG, Aprato A, Di Perri G. Post- traumatic osteomyelitis due to Aspergillus flavus successfully treat- ed with voriconazole: a case report. J Chemother 2008
  6. Beluffi G, Bernardo ME, Meloni G, Spinazzola A, Locatelli F. Spinal osteomyelitis due to Aspergillus flavus in a child: a rare complication after haematopoietic stem cell transplantation. Pediatr Radiol 2008
  7. [CrossRef] 7. Stodulski D, Kowalska B, Stankiewicz C. Otogenic skull base osteomyelitis caused by invasive fungal infection. Case report and literature review. Eur Arch Otorhinolaryngol 2006
  8. [CrossRef] 8. Chi CY, Fung CP, Liu CY. Aspergillus flavus epidural abscess and osteomyelitis in a diabetic patient. J Microbiol Immunol Infect 2003
  9. Tang TJ, Janssen HL, van der Vlies CH, et al. Aspergillus osteo- myelitis after liver transplantation: conservative or surgical treatment? Eur J Gastroenterol Hepatol 2000
  10. [CrossRef] 10. Cimerman M, Gunde-Cimerman N, Zalar P, Perkovic T. Femur osteomyelitis due to a mixed fungal infection in a previously healthy man. J Clin Microbiol 1999
  11. Hovi L, Saarinen UM, Donner U, Lindqvist C. Opportunistic osteomyelitis in the jaws of children on immunosuppressive chemotherapy. J Pediatr Hematol Oncol 1996
  12. [CrossRef] 12. Stratov I, Korman TM, Johnson PD. Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review. Eur J Clin Microbiol Infect Dis 2003